Format

Send to

Choose Destination
Pancreas. 2008 Jul;37(1):1-12. doi: 10.1097/MPA.0b013e318161b99a.

Negative control of human pancreatic secretion: physiological mechanisms and factors.

Author information

1
Département de médecine, Service de Gastroentérologie, Faculté demédecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, Quebec, Canada. jean.morisset@USherbrooke.ca

Abstract

The negative control of pancreatic exocrine secretion in man occurs during the interdigestive and postprandial periods of the digestive cycle. The physiological mechanisms involved include negative feedback mechanisms, well described and accepted in animals, and controlled by the cholecystokinin- and secretin-releasing factors of pancreatic and duodenal origin, along with the active pancreatic proteases present in the upper gut. The presence of these factors and their efficacy in humans, however, have their supporters and detractors, with a possibility for reconciliation among opponents. Besides these releasing factors, hormones, mostly from the intestine, are also involved in this inhibitory process of pancreatic secretion. Somatostatin, peptide YY, pancreatic polypeptide, glucagon, ghrelin, and leptin were described as potentially involved from studies mostly performed on animals. Finally, bile and bile salts have mixed responses on this inhibition, and their effects seem to be at the intestine level with gastrointestinal hormones involved. Future studies will have to be performed in humans to determine the presence of cholecystokinin- and secretin-releasing factors and their role. Finally, the demonstrated modulatory action of hormones and bile acids in other species needs to be confirmed in humans.

PMID:
18580437
DOI:
10.1097/MPA.0b013e318161b99a
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center